Beijing Beilu Pharmaceutical Co Ltd Class A 300016
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- CNY 4.94
- Day Range
- CNY 4.98–5.10
- 52-Week Range
- CNY 3.58–8.93
- Bid/Ask
- CNY 5.09 / CNY 5.10
- Market Cap
- CNY 2.50 Bil
- Volume/Avg
- 8.8 Mil / 12.2 Mil
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 2.71
- Dividend Yield (Trailing)
- 1.38%
- Dividend Yield (Forward)
- 1.38%
- Total Yield
- 1.38%
Company Profile
Beijing Beilu Pharmaceutical Co Ltd is engaged in the research and development, production, and sales of pharmaceutical products. The products of the company are contrasted agent series, psychotropic, and hypoglycemic products which include iopamidol injection, iodixanol injection, and reglinide tablets.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Small Core
- Total Number of Employees
- 923
- Website
- http://www.beilu.com.cn
Comparables
Valuation
|
Metric
|
300016
|
600211
|
002693
|
|---|---|---|---|
Price/Earnings (Normalized) | — | 10.88 | — |
Price/Book Value | 1.51 | 3.56 | 4.85 |
Price/Sales | 2.71 | 4.44 | 11.59 |
Price/Cash Flow | 42.61 | 11.66 | 290.03 |
Price/Earnings
300016
600211
002693
Financial Strength
|
Metric
|
300016
|
600211
|
002693
|
|---|---|---|---|
Quick Ratio | 2.84 | 2.75 | 0.44 |
Current Ratio | 3.76 | 2.87 | 0.74 |
Interest Coverage | −0.39 | 82.65 | −0.28 |
Quick Ratio
300016
600211
002693
Profitability
|
Metric
|
300016
|
600211
|
002693
|
|---|---|---|---|
Return on Assets (Normalized) | −2.34% | 15.20% | −4.75% |
Return on Equity (Normalized) | −3.88% | 21.09% | −8.05% |
Return on Invested Capital (Normalized) | −1.18% | 17.25% | −4.32% |
Return on Assets
300016
600211
002693
Drug Manufacturers - Specialty & Generic Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
ZTS
| Zoetis Inc Class A | Fprcvfpln | Hjhwb | $76.2 Bil | |
MKKGY
| Merck KGaA ADR | Trxvjqcjg | Strtfq | $70.9 Bil | |
HLN
| Haleon PLC ADR | Sbwkpmld | Rlznp | $37.8 Bil | |
VTRS
| Viatris Inc | Zzghfvhv | Dkssw | $14.0 Bil | |
RDY
| Dr Reddy's Laboratories Ltd ADR | Hkhbqwfd | Zlh | $12.7 Bil | |
CTLT
| Catalent Inc | Vyjvrhztn | Ffqltb | $10.2 Bil | |
PRGO
| Perrigo Co PLC | Ssgkxdfg | Vkyrb | $4.4 Bil | |
CURLF
| Curaleaf Holdings Inc | Zrhbfkbpg | Wdjn | $4.1 Bil | |
PBH
| Prestige Consumer Healthcare Inc | Flhlgmws | Wrlym | $3.5 Bil | |
GTBIF
| Green Thumb Industries Inc | Wbdzwnnjr | Mybm | $3.1 Bil |